Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 16,720 | 19,801 | 18,737 | 22,643 | 21,277 |
| Cost of Goods | 10,011 | 10,456 | 10,416 | 11,734 | 10,461 |
| Gross Profit | 6,709 | 9,345 | 8,321 | 10,909 | 10,816 |
| Operating Expenses | 19,728 | 17,747 | 16,394 | 17,325 | 16,158 |
| Operating Income | -13,008 | -7,946 | -7,657 | -5,682 | -4,881 |
| Interest Expense | 665 | 92 | 86 | 21 | 11 |
| Other Income | -27 | 17 | -14 | 0 | 223 |
| Pre-tax Income | -13,699 | -8,021 | -7,757 | -5,702 | -4,669 |
| Income Tax | N/A | N/A | N/A | N/A | 1 |
| Net Income Continuous | -13,699 | -8,021 | -7,757 | -5,702 | -4,670 |
| Net Income | $-13,699 | $-8,021 | $-7,757 | $-5,702 | $-4,670 |
| EPS Basic Total Ops | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 |
| EPS Basic Continuous Ops | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 |
| EPS Diluted Total Ops | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 |
| EPS Diluted Continuous Ops | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.24 | -0.29 | -0.30 | N/A |
| EBITDA(a) | $-12,122 | $-7,313 | $-7,187 | $-5,315 | $-4,415 |